Cardiovascular Tissue Registry, Canada

Certification Status: Documents Required

Registration Status: Completed

Objective: The Cardiovascular Tissue Registry at the Centre for Heart Lung Innovation was established over 30 years ago to provide a unique resource for heart disease researchers worldwide. It houses over 14,000 cases of heart and blood vessel specimens, each of which has been well preserved and is annotated with clinical and demographic information. This repository of biological specimens can be accessed by any researcher with an interest in learning more about cardiovascular disease development, progression, or treatment.

Registered Biobank Name	Cardiovascular Tissue Registry
Biobank Leader	Paul Hanson
Country	Canada
Email for biobank inquiries	info@heartbiobank.ca
Principal Investigator	Paul Hanson
Website	http://heartbiobank.ca/
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).